Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Exploring the comorbidities associated with osteoarthritis

Osteoarthritis is the most common arthritis worldwide, and has an increasing global burden of disability and healthcare utilization.

14 Jun 2024

Study uncovers gut microbes' role in childhood obesity

Researchers used Mendelian randomization to identify causal links between gut microbes and childhood obesity, revealing key microbial players that influence pediatric adiposity.

10 Jun 2024

Berotralstat: A promising oral treatment for hereditary angioedema with normal C1-inhibitor

BioCryst Pharmaceuticals, Inc. today announced new real-world evidence showing that patients with hereditary angioedema (HAE) who have normal C1-inhibitor (HAE-nC1-INH) level and function had a reduction in monthly attack rates after starting oral, once-daily berotralstat.

8 Jun 2024

Health experts call for a renewed focus on allergy training for nurses

Hives, asthma, or eczema – they’re all very common symptoms of an allergic reaction. When mild, allergies cause irritation and discomfort, yet when severe, they can result in anaphylaxis and even death.

8 Jun 2024

Using AI to revolutionize mosquito surveillance to help combat malaria in Africa

University of South Florida researchers are using artificial intelligence to revolutionize mosquito surveillance to help combat malaria in Africa.

8 Jun 2024

Curcumin-based inhibition of thiol isomerases: A potential treatment for food allergies

Clinton Mathias, associate professor of nutritional sciences in the College of Agriculture, Health and Natural Resources (CAHNR), has discovered a potential new treatment for allergic reactions.

7 Jun 2024

KFF Health News' 'What the Health?': Nursing home staffing rules prompt pushback

It's not surprising that the nursing home industry is filing lawsuits to block new Biden administration rules requiring minimum staffing at facilities that accept federal dollars.

6 Jun 2024

Unraveling the role of follicular helper lymphocytes in antibody production against viruses and allergies

The production of antibodies, essential for protecting our body against infections, is very well regulated through the action of a specific subtype of immune system cells, follicular helper lymphocytes.

4 Jun 2024

VUMC researchers discover potent antibody against influenza B

Researchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately affects children, the elderly and other immunocompromised individuals.

31 May 2024

After grilling an NIH scientist over covid emails, Congress turns to Anthony Fauci

Former National Institutes of Health official Anthony Fauci has faced many hostile questions from members of Congress, but when he appears before a House panel on Monday, he'll have something new to answer for: a trove of incendiary emails written by one of his closest advisers.

31 May 2024

Engineered immunogens show promise in inducing HIV broadly neutralizing antibodies

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune systems to induce rare precursor B cells of a class of HIV broadly neutralizing antibodies (bNAbs).

30 May 2024

Inexpensive “duckbill” N95 becomes the champion in COVID-19 mask effectiveness

In a head-to-head comparison of masks worn by people with active COVID-19, the inexpensive "duckbill" N95 came out on top, stopping 98% of COVID-19 particles in the breath of infected people from escaping into the air.

30 May 2024

Existing drug alleviates symptoms of a rare genetic syndrome

A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).

30 May 2024

Early peanut consumption slashes allergy risk by 71%, landmark study finds

A recent study published in NEJM Evidence found that feeding children peanut products regularly from infancy to age five reduced the rate of peanut allergy in adolescence by 71%, providing long-term prevention through early allergen consumption

29 May 2024

New antibiotic lolamicin shows promise in fighting drug-resistant infections

Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut.

29 May 2024

Johns Hopkins researchers propose a novel approach to addressing kidney donor shortage

Researchers from Johns Hopkins Medicine propose a novel approach to addressing the pressing issue of a kidney donor shortage through findings that suggest a promising method to expand the pool of available kidney donors by utilizing deceased donors on dialysis for kidney transplants.

28 May 2024

New point-of-care test revolutionizes toxoplasmosis screening

An inexpensive, accurate test that detects infections with the parasite Toxoplasma gondii can provide results within 30 minutes from a finger-prick in a doctor's office or within an hour from a small blood sample tested in a local medical laboratory.

28 May 2024

Early peanut introduction reduces allergy risk by 71% in adolescents

Feeding children peanuts regularly from infancy to age five reduced the rate of peanut allergy in adolescence by 71%, even after many years when the children ate or avoided peanut as desired.

27 May 2024

Study reveals low adoption of recommended smart inhaler therapy for asthma

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and allergy clinicians have not adopted this optimal therapy, according to research published at the ATS 2024 International Conference.

21 May 2024

Human body lice more efficient at transmitting Yersinia pestis than previously thought

A new laboratory study suggests that human body lice are more efficient at transmitting Yersinia pestis, the bacterium that causes plague, than previously thought, supporting the possibility that they may have contributed to past pandemics.

21 May 2024

Allergy News and Research

Further Reading

Exploring the comorbidities associated with osteoarthritis

Study uncovers gut microbes' role in childhood obesity

Berotralstat: A promising oral treatment for hereditary angioedema with normal C1-inhibitor

Health experts call for a renewed focus on allergy training for nurses

Using AI to revolutionize mosquito surveillance to help combat malaria in Africa

Curcumin-based inhibition of thiol isomerases: A potential treatment for food allergies

KFF Health News' 'What the Health?': Nursing home staffing rules prompt pushback

Unraveling the role of follicular helper lymphocytes in antibody production against viruses and allergies

VUMC researchers discover potent antibody against influenza B

After grilling an NIH scientist over covid emails, Congress turns to Anthony Fauci

Engineered immunogens show promise in inducing HIV broadly neutralizing antibodies

Inexpensive “duckbill” N95 becomes the champion in COVID-19 mask effectiveness

Existing drug alleviates symptoms of a rare genetic syndrome

Early peanut consumption slashes allergy risk by 71%, landmark study finds

New antibiotic lolamicin shows promise in fighting drug-resistant infections

Johns Hopkins researchers propose a novel approach to addressing kidney donor shortage

New point-of-care test revolutionizes toxoplasmosis screening

Early peanut introduction reduces allergy risk by 71% in adolescents

Study reveals low adoption of recommended smart inhaler therapy for asthma

Human body lice more efficient at transmitting Yersinia pestis than previously thought

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News